Heidi CEO on AI in Healthcare, $900M valuation
THE SO WHAT
A $100M round at a $900M valuation for an AI healthcare startup underscores how much capital believes in workflow-level tools for clinicians. Hospital and clinic operators should expect rapid vendor turnover — and negotiate hard on integration and liability.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureExclusive: Connect Ventures raises $55m in first close of fifth fund to chase deeptech founders
More early-stage capital explicitly chasing deeptech means longer runways for teams with heavy R&D and slower sales cycles. If you’re building in hard tech, assume seed expectations are rising on technical depth and IP, not just GTM polish.
Startups & VentureExclusive: VSquared and East X lead £10m seed for rare materials startup
Rare materials are moving from commodity exposure to venture-scale thesis as supply chains politicize. Hardware and energy operators should expect more startup options — and more volatility — in their upstream inputs over the next 3–7 years.
Startups & VentureFrom one of Europe’s biggest fintech exits to bootstrapping an AI startup: ‘There’s no limitation’
Repeat founders coming off large fintech exits and choosing to bootstrap AI products suggests they expect capital efficiency and fast revenue, not multi-year infra burn. If you’re competing in that space, assume your rival’s constraint is distribution, not fundraising.
Startups & VentureGo.AI, which offers on-premises AI hardware and software tools for regulated organizations like banks, raised an $85M Series A led by Updata Partners
An $85M Series A for on-prem AI appliances into banks says regulated industries want AI, but not at the mercy of public cloud and data residency risk. If you sell into regulated orgs, expect RFPs to bifurcate: one track for SaaS, one for controlled, on-prem or sovereign options.